BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choo J, Heo G, Pothoulakis C, Im E. Posttranslational modifications as therapeutic targets for intestinal disorders. Pharmacol Res 2021;165:105412. [PMID: 33412276 DOI: 10.1016/j.phrs.2020.105412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Roskoski R. Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update. Pharmacological Research 2021;165:105463. [DOI: 10.1016/j.phrs.2021.105463] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 37.0] [Reference Citation Analysis]
2 Roskoski R Jr. Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update. Pharmacol Res 2021;175:106037. [PMID: 34921994 DOI: 10.1016/j.phrs.2021.106037] [Reference Citation Analysis]